Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy

NCT00754845 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1918

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: letrozole
OTHER: placebo

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]